3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Unknown
2
Recruiting
2
Withdrawn
1
Not yet recruiting
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Lung Neoplasms
4
Head and Neck Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Glioblastoma
3
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Glioma
2
Endometrial Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Sarcoma
1
Rhabdoid Tumor
1
Renal Insufficiency
1
Recurrence
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Postoperative Complications
1
Pancreatic carcinoma, familial
1
Interventions
Tacrolimus
2
Specimen Handling
2
Lymphatic Irradiation
2
Biopsy
2
venetoclax
1
selinexor
1
olutasidenib
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Thiotepa
1
Sirolimus
1
Receptors, Antigen, T-Cell
1
Quality of Life
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Maintenance
1
Levofloxacin
1
Idarubicin
1
Fibroblast Growth Factor 7
1
Electrocardiography
1
Cytarabine
1
Clinical Laboratory Techniques
1
Busulfan
1
Bone Marrow Examination
1
Blood Specimen Collection
1
Azacitidine
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Myelodysplastic Syndromes
×
Blood Specimen Collection
×
Clear all
NCT07249476
2026-04-29
ENKLA-M
Nantes University Hospital
Not yet recruiting
55 enrolled